A Phase III Trial of Accelearated Whole Breast Irradiation with Hypofractionation plus Concurrent Boost versus Standard Whole Breast Irradiation plus Sequential Boost for Early-Stage Breast Cancer (RTOG 1005)
Eligibility Criteria
- At least 18 years of age
- Pathologically proven diagnosis of breast cancer resected by lumpectomy and whole breast irradiation with boost without regional nodal irradiation planned
- The patient must be female
- pStage 0 breast cancer with nuclear grade 3 DCIS and Patient age < 50 years
- ypStage 0, I, II breast cancer resected by lumpectomy after Neoadjuvant systemic therapy
- Study entry must be within 42 days of last breast/axillary surgery and/or last chemotherapy
- If multifocal breast cancer, then it must have been resected through a single lumpectomy incision with negative margins
Please contact Jamie Holt at (520) 626-6800 for further information regarding our clinical trials.